Brinker Capital Investments, LLC Meridian Bioscience Inc Transaction History
Brinker Capital Investments, LLC
- $5.01 Billion
- Q4 2022
A detailed history of Brinker Capital Investments, LLC transactions in Meridian Bioscience Inc stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 16,001 shares of VIVO stock, worth $0. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,001
Previous 32,225
50.35%
Holding current value
$0
Previous $1.02 Million
47.74%
% of portfolio
0.01%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding VIVO
# of Institutions
10Shares Held
113KCall Options Held
0Put Options Held
0-
Havens Advisors LLC New York, NY26.8KShares$02.29% of portfolio
-
Telemetry Investments, L.L.C. New York, NY20.3KShares$01.06% of portfolio
-
Advisor Partners LLC Walnut Creek, CA19.7KShares$00.04% of portfolio
-
Sarissa Consulting LLC Santa Monica, CA18.3KShares$00.59% of portfolio
-
Hightower 6 M Holding, LLC11.8KShares$00.03% of portfolio
About MERIDIAN BIOSCIENCE INC
- Ticker VIVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 43,748,000
- Description
- Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...